Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Malignant Hemopathy
Interventions
OTHER

Blood samples

"A peripheral blood sample will be taken and will include 2 EDTA tubes of 5 mL, for a total volume of 10 mL:~* Samples before the allograft,~* Samples at different times post-allograft: 15 days, 30 days, 60 days, 90 days, 180 days, 360 days,~* Samples in the event of the occurrence of concomitant events during the 12-month follow-up period: occurrence of acute Graft Versus Host Disease, chronic Graft Versus Host Disease, or relapse of the disease before the initiation of a new treatment."

Trial Locations (1)

42055

RECRUITING

CHU de Saint-Etienne, Saint-Etienne

All Listed Sponsors
collaborator

Institut de Cancérologie de la Loire

OTHER

collaborator

Jean Monnet University

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER